Article Sidebar
Published:
May 31, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Salvia miltiorrhiza injection ameliorates myocardial ischemia-reperfusion injury via downregulation of PECAM-1
Abstract
Purpose: To investigate the effect of Salvia miltiorrhiza injection on myocardial ischemia-reperfusion injury and PECAM-1 related pathways.
Method: Male Wistar rats were used for establishment of myocardial ischemia-reperfusion model. The rats were randomly assigned to four groups: experimental group, low dose group (Salvia miltiorrhiza injection, 10 mL/kg/day), moderate dose group (Salvia miltiorrhiza injection, 20 mL/kg/day) and high dose group (Salvia miltiorrhiza injection, 40 mL/kg/day). Myocardial ischemia-reperfusion model was established in the four groups. Evans-TTC staining was used to assess relative area of ischemiareperfusion injury. Blood samples were collected for assay of PECAM-1 expression using enzymelinked immunosorbent assay (ELISA). Fresh blood platelets were collected in all groups, and divided into two groups - control group (normal culture) and experimental group (Salvia miltiorrhiza injection). The expression of PECAM-1 in blood platelets was assayed using Western blot.
Result: Compared with the experimental group, Salvia miltiorrhiza injection ameliorated myocardial ischemia-reperfusion injury, and decreased the infarction area seen in Evans/TTC staining. PECAM-1 expression in blood was decreased by Salvia miltiorrhiza injection. Blood platelets dysfunction was induced after myocardial ischemia-reperfusion, and the level of PECAM-1 increased. However, Salvia miltiorrhiza injection treatment downregulated the expression of PECAM-1 after myocardial ischemiareperfusion.
Conclusion: Salvia miltiorrhiza injection maintains normal function of blood platelets and ameliorates myocardial ischemia-reperfusion injury by decreasing expression of PECAM-1.
